Phase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKI

Clinical trial NCT05869162 · UNKNOWN

Trial details

NCT number: NCT05869162
Sponsor: Shouyao Holdings (Beijing) Co. LTD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Carcinoma

Start date: 2023-06-30
Primary completion: 2025-06-10
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.